Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/20/1992 | EP0485970A2 Transgenic plants overproducing threonine and lysine |
05/20/1992 | EP0485701A1 Insertion of DNA by modified transposons |
05/20/1992 | EP0485689A1 Cells growing in protein-free medium, and enhancing replication of exogenous genes |
05/20/1992 | EP0485611A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
05/20/1992 | EP0485608A1 Method for obtaining polypeptides in a cell-free translation system |
05/20/1992 | EP0485569A1 Cholesterol esterases with variable substrate specificity |
05/20/1992 | EP0485532A1 Fucosyl transferases involved in adhesion molecule expression |
05/20/1992 | EP0485506A1 Methods and compositions for the production of stably transformed, fertile maize plants and cells thereof |
05/20/1992 | EP0485504A1 Cell culture methods for producing activated protein c. |
05/20/1992 | EP0485497A1 Il-2 deletion mutants |
05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
05/20/1992 | EP0485407A1 Proteins with tnf activity |
05/20/1992 | EP0477285A4 Processes for the recovery of microbially produced chymosin |
05/20/1992 | EP0477284A4 Processes for the recovery of naturally produced chymosin |
05/20/1992 | EP0466811A4 Brassica linkage map |
05/20/1992 | EP0465572A4 Genetic engineering of novel plant phenotypes |
05/20/1992 | EP0401369A4 Method for preparative expression of genes in a cell-free system of conjugated transcription/translation |
05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
05/20/1992 | EP0229110B1 Solubilization and oxidation of somatotropin from transformed microorganisms |
05/20/1992 | EP0217854B1 Method for the monitoring and control of microbial populations |
05/20/1992 | EP0216864B1 Detection of activated platelets with antibodies to cell surface antigens |
05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
05/20/1992 | CN1061245A Bioassay for detention of b. burgdorferi |
05/19/1992 | US5115102 Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
05/19/1992 | US5115096 Amphiregulin: a bifunctional growth modulating glycoprotein |
05/19/1992 | US5114922 Animal extracts from leeches |
05/19/1992 | US5114853 Generic engineering |
05/19/1992 | US5114852 Chimeric fused monooxygenase of cytochrome P-450 and NADPH-cytochrome P-450 reductase |
05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
05/19/1992 | US5114844 Immunoassay with a protein or antibody |
05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
05/19/1992 | US5114839 Process for dna sequencing using oligonucleotide bank |
05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
05/19/1992 | CA1301095C Human che type proteins and their production |
05/19/1992 | CA1301094C Bacillus thuringiensis crystal protein gene toxin segment |
05/18/1992 | CA2055635A1 Antiviral activity of the rep gene encoded by adenoassociated virus type 2 |
05/17/1992 | WO1992008792A2 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
05/17/1992 | WO1992008786A1 Human rotaviruses, vaccines and methods |
05/17/1992 | CA2096329A1 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
05/16/1992 | WO1992008726A1 Rat thyrotropin receptor gene and uses thereof |
05/16/1992 | CA2095013A1 Rat thyrotropin receptor gene and uses thereof |
05/15/1992 | WO1992008794A1 Herbicide resistant plants |
05/15/1992 | CA2096348A1 Herbicide resistant plants |
05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
05/14/1992 | WO1992008800A1 Nucleic acid amplification by two-enzyme, self-sustained sequence replication |
05/14/1992 | WO1992008796A1 Bifunctional selectable fusion genes |
05/14/1992 | WO1992008133A1 Isolation of biological materials using magnetic particles |
05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
05/14/1992 | WO1992008117A1 Method of determining a genotype by comparing the nucleotide sequence of members of a gene family and kit therefor |
05/14/1992 | WO1992007960A1 Method of detecting non-a non-b hepatitis specific gene and reagent composition used therefor |
05/14/1992 | WO1992007950A1 Method of gene transfer using retrotransposons |
05/14/1992 | WO1992007949A1 Method for the in vitro production of protein from a dna sequence without cloning |
05/14/1992 | WO1992007945A1 Cell type specific alteration of levels of gene products in neural cells |
05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
05/14/1992 | WO1992007940A2 Bovine respiratory syncytial virus genes |
05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
05/14/1992 | WO1992007938A1 Cell growth inhibitors |
05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
05/14/1992 | WO1992007936A1 Cloning and expression of biologically active alpha-n-acetylgalactosaminidase |
05/14/1992 | WO1992007935A1 Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions |
05/14/1992 | WO1992007865A1 Human gene encoding adrenodoxin reductase |
05/14/1992 | WO1992007863A1 Device and process for insulating nucleic acids from cell suspensions |
05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
05/14/1992 | WO1992002621A3 Allergens of alder pollen and applications thereof |
05/14/1992 | WO1992001814A3 The reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases |
05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
05/14/1992 | WO1991002071A3 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
05/14/1992 | CA2096013A1 Nucleic acid amplification by two-enzyme, self-sustained sequence replication |
05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
05/14/1992 | CA2094922A1 Cloning and expression of biologically active alpha-n-acetylgalactosaminidase |
05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
05/14/1992 | CA2072581A1 Method of gene transfer using retrotransposons |
05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
05/13/1992 | EP0485347A2 Recombinant hepatitis delta antigen, process for the purification and use thereof |
05/13/1992 | EP0485209A1 Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
05/13/1992 | EP0485044A2 Plasmids for the production of transgenic plants that are modified in habit and yield |
05/13/1992 | EP0484863A1 A monoclonal antibody and a method for measuring malondialdehyde-reacted low-density-lipoproteins |
05/13/1992 | EP0484787A2 HCV-specific peptides, process for obtaining them and their use |
05/13/1992 | EP0484500A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
05/13/1992 | EP0484452A1 Fibulin |
05/13/1992 | EP0484440A1 Efficient directional genetic cloning system |
05/13/1992 | EP0484416A1 Regulation of nerve growth factor synthesis in the central nervous system |
05/13/1992 | EP0484411A1 Prevention of internal initiation |
05/13/1992 | EP0484396A1 Avipox virus promoters |
05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
05/13/1992 | EP0484369A1 Modified bioluminescent proteins and their use |
05/13/1992 | EP0448650A4 Herpes simplex virus type i expression vector |
05/13/1992 | EP0446299A4 Method for site-specifically incorporating unnatural amino acids into proteins |
05/13/1992 | EP0386228A4 Replicative rna-based amplification/detection systems |
05/13/1992 | CN1016645B Target and background capture methods and apparatus for affinity assays |
05/13/1992 | CN1016574B Pollen-mediated plant transformation |
05/12/1992 | US5112963 Modified oligonucleotides |
05/12/1992 | US5112961 Granulocyte-macrophage colony stimulating factor |